Requip (Ropinirole) – Patient Guide (Australia)

Requip is a medicine containing ropinirole, used to treat certain movement disorders—most commonly Restless Legs Syndrome (RLS) and Parkinson’s disease. This guide explains how it works, how it’s usually taken, common side effects, key safety points, and practical tips to help you use Requip confidently.

Always follow the instructions on your medicine label and the advice provided by your healthcare professional. If you’re unsure about anything in this guide, ask a pharmacist or doctor.

Key product information

How Requip works (mechanism of action)

Ropinirole belongs to a group of medicines called dopamine agonists. In simple terms, it works by mimicking the effects of dopamine—a natural chemical messenger involved in movement and muscle control.

In the brain, Requip activates dopamine receptors (particularly D2/D3 receptors), which helps improve the abnormal signalling linked to:

• Restless Legs Syndrome: reduces uncomfortable leg sensations and urges to move, especially at rest and in the evening.
• Parkinson’s disease: improves movement symptoms such as stiffness, slowness, and tremor.

Pharmacokinetics (how the body handles Requip)

Understanding pharmacokinetics can help you use the medicine more safely—especially regarding timing, missed doses, and interactions.

• Absorption: Ropinirole is absorbed after oral dosing. How quickly it reaches peak levels depends on whether you take an immediate-release or prolonged-release formulation.
• Distribution: The medicine distributes into body tissues and acts primarily in the central nervous system.
• Metabolism: Ropinirole is mainly metabolised by liver enzymes, especially the CYP1A2 pathway.
• Elimination: It is cleared from the body mainly through metabolism, with metabolites removed via normal body waste processes.

Because liver enzymes play a key role, some medicines (and smoking) can significantly change ropinirole levels in your body.

Typical uses (indications)

Requip (ropinirole) is used for:

• Restless Legs Syndrome (RLS): Helps reduce symptoms such as uncomfortable sensations in the legs and the urge to move, often worsening during evenings or at night.
• Parkinson’s disease: Helps manage symptoms by improving movement. It may be used alone or alongside other Parkinson’s medicines, depending on your situation.

When to take Requip (timing guidance)

Restless Legs Syndrome

For RLS, dosing is commonly scheduled to cover the time when symptoms are most troublesome—often in the evening. Many people take their dose about 1–3 hours before bedtime, but follow your prescribed schedule.

Parkinson’s disease

For Parkinson’s disease, dosing schedules vary depending on dose and whether a prolonged-release product is used. You may take Requip one or more times per day. Your regimen is usually adjusted gradually and then maintained.

Missed dose

• If you miss a dose, take it when you remember unless it’s near the next dose.
• If it’s close to the next dose, skip the missed dose and continue as normal.
• Do not double up unless your healthcare professional specifically tells you to.

If you have had a significant break in treatment, restarting may require a titration approach—confirm what to do after missed days with a pharmacist or doctor.

Dose and how dosing is adjusted

Requip dosing is individualised. In many cases, treatment begins with a lower dose and increases gradually to minimise side effects while achieving symptom control.

General dosing principles

• Start low: initial doses are typically smaller than the eventual maintenance dose.
• Titrate gradually: increases are usually spaced out so you can monitor response and tolerability.
• Formulation matters: immediate-release and prolonged-release products are not always interchangeable on a mg-for-mg basis.
• Individual factors: age, kidney function, liver function, and other medicines may affect dosing decisions.

Typical dose schedules (high-level overview)

Exact dosing depends on the formulation strength and your condition. As a general guide, prescribers often use step-wise dose changes over days to weeks. Your local label instructions should be treated as the authority for your dosing.

If you are using Requip for RLS, your doctor may adjust dose based on symptom relief and monitoring for a phenomenon called augmentation (worsening of RLS symptoms over time, sometimes earlier in the day).

Food interactions and what to eat

Food can influence the absorption rate of ropinirole, particularly with immediate-release formulations.

Practical food guidance

• If you take ropinirole with food, absorption may be slower or slightly reduced, which can affect how quickly you feel effects.
• Try to take your doses consistently in relation to meals (e.g., always with food or always on an empty stomach) unless your healthcare professional advises otherwise.

For RLS, maintaining a consistent routine (meal timing and bedtime timing) can help keep symptom control steady through the evening.

Alcohol and other medicine interactions

Alcohol

Alcohol can increase the risk of side effects such as dizziness, drowsiness, and impaired coordination. Combining alcohol with Requip may also worsen balance problems and increase fall risk—especially at night.

If you choose to drink, consider limiting alcohol and avoid drinking close to bedtime when RLS symptoms often peak. Use caution when driving or operating machinery.

Other medicines (important interaction considerations)

Because ropinirole is metabolised through CYP1A2, medicines that affect this liver pathway can change ropinirole levels. Some medicines may increase side effects by raising ropinirole exposure; others may reduce its effectiveness.

Tell your pharmacist or doctor about all medicines you take, including:

• Other medicines for Parkinson’s disease
• Antipsychotics or anti-nausea medicines
• Antidepressants and sleep medicines
• Antibiotics (some may interact via liver enzymes)
• Anticonvulsants (antiepileptics)
• Medicines for nausea/vomiting
• Herbal products and supplements

Smoking

While not an “alcohol” interaction, smoking is clinically relevant because tobacco smoke can affect CYP1A2 activity. If you smoke, recently quit, or plan to quit, discuss this with your pharmacist or doctor—your Requip dose may need review.

Safety profile: common and important side effects

Common side effects

Side effects often occur early in treatment or after dose increases and may lessen as your body adjusts. Commonly reported effects include:

• Nausea (sometimes mild, sometimes requiring attention)
• Dizziness
• Sleepiness or fatigue
• Headache
• Low blood pressure symptoms (such as lightheadedness, especially when standing)
• Swelling in the legs/ankles (less common)
• Heartburn or indigestion (less common)

Serious or urgent warning signs

Seek medical advice promptly (or emergency help if severe) if you experience:

• Severe drowsiness or sudden onset of sleep during daily activities
• Hallucinations, confusion, or marked changes in behaviour
• Fainting or severe dizziness that could lead to falls
• Allergic reaction such as swelling of the face/lips, trouble breathing, or rash
• Uncontrolled movements (for Parkinson’s disease patients, this may relate to medication balance)
• New impulse-control problems (see below)

Impulse control and behavioural changes

Dopamine agonists (including ropinirole) have been associated with impulse-control disorders in some people. This may include behaviours such as:

• Compulsive gambling
• Increased libido
• Compulsive shopping or spending
• Compulsive eating
• Other unusual urges or behaviours

If you or your family notice changes in behaviour or urges, contact your healthcare professional. Do not stop the medicine abruptly without guidance.

Sleep-related effects

Requip may cause drowsiness and, in some cases, sudden sleep onset. Be especially cautious:

• When starting treatment
• After increasing the dose
• When taking other medicines that cause sedation
• When using alcohol

Avoid driving or operating machinery if you feel sleepy or at risk of falling asleep.

Practical use tips for best results

1) Take it at the same time each day

Consistency can improve symptom control and reduce the chance of side effects related to peaks and troughs. If your routine changes, discuss timing changes with your pharmacist.

2) Start-up and dose changes

If you’re at the start of treatment or after a dose increase, plan extra caution:

• Be careful when standing up quickly
• Avoid alcohol and sedative medicines unless your healthcare professional approves
• Monitor sleepiness during the day

3) Keep track of symptom patterns

For RLS, note:

• When symptoms start (earlier or later than before?)
• How severe they are
• Whether symptoms are spreading to other body parts
• Whether symptoms appear earlier in the day (possible augmentation)

Report meaningful changes promptly so your clinician can adjust your regimen if needed.

4) Do not stop suddenly

Stopping abruptly can be unsafe. If you need to change or discontinue treatment, a planned approach is often required.

Restless Legs Syndrome: augmentation and long-term considerations

A key issue with RLS treated using dopamine agonists is augmentation—a situation where symptoms worsen and/or start earlier than before. Not everyone experiences augmentation, but it is important to watch for.

Signs may include:

• Symptoms beginning earlier in the day
• Increasing severity of uncomfortable sensations
• Symptoms spreading beyond the legs
• Reduced time between doses becoming necessary

If you suspect augmentation, contact your clinician promptly. Management may involve adjusting the dose, changing treatment, and addressing contributing factors such as low iron levels.

Alternative options (other treatments you may discuss)

Treatment choice depends on the condition (RLS vs Parkinson’s), severity, medical history, and how you respond to therapy. Alternatives may include:

For Restless Legs Syndrome

• Iron therapy if iron deficiency is present (commonly guided by blood tests)
• Alpha-2-delta ligands (e.g., certain gabapentinoids) used in some people
• Non-medicine strategies such as sleep routine adjustments, exercise, and reducing caffeine late in the day

For Parkinson’s disease

• Levodopa-based therapy (often central to Parkinson’s management)
• Other dopamine agonists
• MAO-B inhibitors or other add-on therapies
• Physiotherapy and exercise programs to support mobility and balance

Your healthcare professional can explain which options are most suitable based on symptom control goals and side-effect risks.

Market and legal context in Australia (general information)

In Australia, medicines are regulated under the Australian regulatory framework. Availability may vary by formulation and whether the product is classified as prescription-only or available under different supply arrangements.

For any medicine, online purchasing should comply with Australian requirements, including authorised supply, correct labelling, and safe handling. You should ensure that the online pharmacy you use provides medicines through legitimate channels and offers accurate product information.

If you have questions about supply, packaging, or how to identify authentic medicine, ask the pharmacy.

Recent guidance and monitoring (what to expect)

Over time, clinical guidance for dopamine agonists has emphasised:

• Careful dose titration to reduce side effects
• Monitoring for impulse-control disorders
• Monitoring for sleepiness and driving safety
• RLS augmentation awareness for long-term dopamine agonist use
• Iron status evaluation where appropriate in RLS

Your clinician may also review your medicine regimen periodically, especially if symptoms change or other medicines are added.

Delivery and availability

Requip is generally available through pharmacies in Australia depending on the specific strength and formulation. Delivery options vary by pharmacy and local regulations.

Typical points to consider when ordering online:

• Check formulation/strength: Immediate-release and prolonged-release forms are different.
• Packaging and expiry: Ensure you receive sealed packaging with clearly stated expiry dates.
• Delivery times: Many pharmacies provide estimated dispatch and delivery windows.
• Cold-chain needs: Requip tablets generally do not require refrigeration.

If you are running low, plan ahead—especially for medicines that require careful titration after interruptions.

FAQ

1) What is Requip used for?

Requip (ropinirole) is used for Restless Legs Syndrome and for Parkinson’s disease to improve symptoms.

2) How long does Requip take to work?

Many people notice effects for RLS within days, while Parkinson’s symptom improvement can build over time as doses are adjusted. The exact timeline varies by dose, formulation, and your individual response.

3) Can I take Requip with food?

It may be taken with or without food depending on the formulation and your personal tolerance. Food can influence absorption, so it’s usually best to keep your routine consistent and follow label instructions.

4) Does Requip cause sleepiness?

Yes. Drowsiness and fatigue are possible. Some people may experience sudden sleep onset. Avoid driving or hazardous tasks if you feel sleepy.

5) Is it safe to drink alcohol while taking Requip?

Alcohol may increase dizziness and drowsiness. For safety, limit or avoid alcohol and be extra cautious, particularly at night.

6) What side effects are most common?

Common side effects include nausea, dizziness, sleepiness, and headache. Some people also experience low blood pressure symptoms.

7) What is augmentation in restless legs syndrome?

Augmentation is when RLS symptoms worsen and/or start earlier than before while on dopamine agonist therapy. If you notice this, contact your clinician promptly.

8) What medicines interact with ropinirole?

Interactions can occur with medicines that affect liver enzymes (especially CYP1A2) and those that increase sedation. Always tell your pharmacist about all medicines and supplements you take.

9) What should I do if I miss a dose?

Take it when you remember unless it is near the next dose. If close to the next dose, skip the missed dose and continue. Do not double up.

10) Should I stop Requip suddenly?

Do not stop suddenly unless your healthcare professional advises it. Stopping abruptly may cause problems, and dose changes are often planned gradually.

Disclaimer

This information is provided for general education and does not replace advice from your healthcare professional. If you have questions about suitability, dosing, or side effects, consult a pharmacist or doctor.